跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INFLUVAC TETRA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INFLUVAC TETRA
Authorized
STANDARD
INFLUVAC TETRA
BGP Pharma ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ad384331a74ee255
Company
BGP Pharma ULC
Type
Standard
Approval Details
Approval Id
ad384331a74ee255
Drug Approval Canada Name
INFLUVAC TETRA
Product Name
INFLUVAC TETRA
Status
Marketed
Status Date
2019-10-17
Original Market Date
2019-10-17
Din
02484854
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular , Subcutaneous
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name
j 07 bb 02
Aig Number
0455410003
Company Name
BGP Pharma ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
HAEMAGGLUTININ-STRAIN A (H1N1)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN B (YAMAGATA)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN A (H3N2)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN B (VICTORIA)
15 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ad384331a74ee255
Type
Standard
Back to Health Canada Approvals